These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 27531684)

  • 21. Surveillance for hepatocellular carcinoma: how can we do better?
    Hassett M; Yopp AC; Singal AG
    Am J Med Sci; 2013 Oct; 346(4):308-13. PubMed ID: 23426089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Screening of hepatocellular carcinoma and surveillance of patients with cirrhosis: a public health issue].
    Trinchet JC; Nahon P; Ganne-Carrie N
    Rev Prat; 2013 Feb; 63(2):222-5. PubMed ID: 23513790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States.
    Kim NJ; Rozenberg-Ben-Dror K; Jacob DA; Rich NE; Singal AG; Aby ES; Yang JD; Nguyen V; Pillai A; Fuchs M; Moon AM; Shroff H; Agarwal PD; Perumalswami P; Chandna S; Zhou K; Patel YA; Latt NL; Wong R; Duarte-Rojo A; Lindenmeyer CC; Frenette C; Ge J; Mehta N; Yao F; Benhammou JN; Bloom PP; Leise M; Kim HS; Levy C; Barnard A; Khalili M; Ioannou GN
    Clin Gastroenterol Hepatol; 2022 Jan; 20(1):183-193. PubMed ID: 32927050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.
    Singal AG; Pillai A; Tiro J
    PLoS Med; 2014 Apr; 11(4):e1001624. PubMed ID: 24691105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effect of Hepatocellular Carcinoma Surveillance in an Urban Population With Liver Cirrhosis.
    Nusbaum JD; Smirniotopoulos J; Wright HC; Dash C; Parpia T; Shechtel J; Chang Y; Loffredo C; Shetty K
    J Clin Gastroenterol; 2015; 49(10):e91-5. PubMed ID: 25751372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance.
    Kim GA; Lee HC; Kim MJ; Ha Y; Park EJ; An J; Lee D; Shim JH; Kim KM; Lim YS
    J Hepatol; 2015 May; 62(5):1092-9. PubMed ID: 25445399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proportion of Time Covered by Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis.
    Daher D; Seif El Dahan K; Yekkaluri S; Gopal P; Rich NE; Parikh ND; Murphy CC; Singal AG
    Am J Gastroenterol; 2024 May; 119(5):875-882. PubMed ID: 37975606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Racial, social, and clinical determinants of hepatocellular carcinoma surveillance.
    Singal AG; Li X; Tiro J; Kandunoori P; Adams-Huet B; Nehra MS; Yopp A
    Am J Med; 2015 Jan; 128(1):90.e1-7. PubMed ID: 25116425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suboptimal surveillance for and knowledge of hepatocellular carcinoma among primary care providers.
    McGowan CE; Edwards TP; Luong MU; Hayashi PH
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):799-804. PubMed ID: 25117773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should Patients With NAFLD/NASH Be Surveyed for HCC?
    Reig M; Gambato M; Man NK; Roberts JP; Victor D; Orci LA; Toso C
    Transplantation; 2019 Jan; 103(1):39-44. PubMed ID: 30080818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surveillance for hepatocellular carcinoma: compliance and results according to the aetiology of cirrhosis in a cohort of 141 patients.
    Henrion J; Libon E; De Maeght S; Schapira M; Ghilain JM; Maisin JM; Heller FR
    Acta Gastroenterol Belg; 2000; 63(1):5-9. PubMed ID: 10907311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors affecting screening for hepatocellular carcinoma.
    Al Hasani F; Knoepfli M; Gemperli A; Kollar A; Banz V; Kettenbach J; Jüni P; Dufour JF
    Ann Hepatol; 2014; 13(2):204-10. PubMed ID: 24552862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sarcopenia associates with increased risk of hepatocellular carcinoma among male patients with cirrhosis.
    Feng Z; Zhao H; Jiang Y; He Z; Sun X; Rong P; Wang W
    Clin Nutr; 2020 Oct; 39(10):3132-3139. PubMed ID: 32057535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surveillance of patients with cirrhosis remains suboptimal in the United States.
    Yeo YH; Hwang J; Jeong D; Dang N; Kam LY; Henry L; Park H; Cheung R; Nguyen MH
    J Hepatol; 2021 Oct; 75(4):856-864. PubMed ID: 33965477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA.
    El-Serag HB; Kramer JR; Chen GJ; Duan Z; Richardson PA; Davila JA
    Gut; 2011 Jul; 60(7):992-7. PubMed ID: 21257990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular Carcinoma Surveillance Among Cirrhotic Patients With Commercial Health Insurance.
    Goldberg DS; Valderrama A; Kamalakar R; Sansgiry SS; Babajanyan S; Lewis JD
    J Clin Gastroenterol; 2016 Mar; 50(3):258-65. PubMed ID: 26352107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nurse-led hepatocellular carcinoma surveillance clinic provides an effective method of monitoring patients with cirrhosis.
    Nazareth S; Leembruggen N; Tuma R; Chen SL; Rao S; Kontorinis N; Cheng W
    Int J Nurs Pract; 2016 Jun; 22 Suppl 2():3-11. PubMed ID: 27476494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefits and Harms of Hepatocellular Carcinoma Surveillance in a Prospective Cohort of Patients With Cirrhosis.
    Singal AG; Patibandla S; Obi J; Fullington H; Parikh ND; Yopp AC; Marrero JA
    Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1925-1932.e1. PubMed ID: 32920214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surveillance Rate and its Impact on Survival of Hepatocellular Carcinoma Patients in South Korea: A Cohort Study.
    Im S; Jang ES; Lee JH; Lee CS; Kim BH; Chung JW; Kim JW; Jeong SH
    Cancer Res Treat; 2019 Oct; 51(4):1357-1369. PubMed ID: 30744319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient-, Provider-, and System-Level Barriers to Surveillance for Hepatocellular Carcinoma in High-Risk Patients in the USA: a Scoping Review.
    Beal EW; Owen M; McNamara M; McAlearney AS; Tsung A
    J Gastrointest Cancer; 2023 Jun; 54(2):332-356. PubMed ID: 35879510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.